Sponsor study identifier
observational
150
1 country
1
Study Start
January 1, 2022
Actual (reported)Primary Completion
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
To investigate the relationship between single umbilical artery caused by umbilical artery embolism and pregnancy outcome , and to provide evidence-based evidence for peripartum health care of pregnant women with umbilical artery embolism.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2022
Actual (reported)March 30, 2022
Actual (reported)April 14, 2022
Actual (reported)December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Gestational week of delivery
The gestational age of delivery is determined according to the last menstruation and ultrasonic diagnosis.
32 weeks to 40 weeks gestation
mode of delivery
The mode of delivery including vaginal delivery and cesarean section, is determined by the exact condition of pregnancy.
32 weeks to 40 weeks gestation
newborn birth weight
Newborn weight is measured immediately after birth.
32 weeks to 40 weeks gestation
birth height
Birth height is measured immediately after birth.
32 weeks to 40 weeks gestation
Apgar score
Apgar score is assessed at 1 min and 5 minute after birth.
32 weeks to 40 weeks gestation
coagulation function
32 weeks to 40 weeks gestation
placental weight
32 weeks to 40 weeks gestation
umbilical cord placental insertion point
32 weeks to 40 weeks gestation
umbilical cord length
32 weeks to 40 weeks gestation
pregnant women with Single Umbilical Artery
pregnant women with Umbilical Artery Embolism
Normal pregnant women without pregnancy complications
collect information On age,pregnancy history,Height, weight,Gestational weeks of umbilical artery embolism,Gestational week of delivery, mode of delivery, newborn birth weight, birth height, Apgar score, umbilical cord length, umbilical cord placental insertion point, placental weight, pregnancy complications, coagulation function,after obtaining the consent of all participants.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The participants include women with pregnancy meeting the inclusion criteria
department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325027, China
Ying Hua
Second Affiliated Hospital of Wenzhou Medical University
First Submitted
March 30, 2022
First Posted
April 14, 2022
Study Start
January 1, 2022
Actual (reported)Primary Completion
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Contact the study team to confirm eligibility.
Study Completion
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 14, 2022
Record last verified: 2022-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: